Sustainable marine biotech

The medicine of tomorrow

Hofseth BioCare is processing marine raw material into products to enhance global health.

Reasons to invest
Our value

Research & Development

Hofseth BioCare is processing marine raw material into products to enhance global health.

Read more

Latest news

Featured

Aquaculture fund new significant shareholder in HBC

04.11.2021 - The global investment fund Aqua Spark has acquired a substantial number of shares in Hofseth BioCare ASA. Aqua Spark's purchase represents a 3.38 % stake in HBC.

Read more
Zubair
HBC strengthens capacity on regulatory affairs
Tanja
Dr. Tanja Schaffer joins HBC to lead new Swiss operation
The Oils Advantage still 5
New partnership with the world leading pharmacy company Catalent
Get notified
We care about your data privacy. Read about our privacy policy

Latest stock exchange notices

Stock Exhange Notices

COMPLETED EXTRAORDINARY GENERAL MEETING

03.12.2021

HBC INGREDIENTS SUCCESSFULLY RECEIVE NEW DIETARY INGREDIENT (NDI) STATUS FROM THE US FDA

02.12.2021

MANDATORY NOTIFICATION OF TRADE

18.11.2021

NOTICE OF EXTRAORDINARY GENERAL MEETING

08.11.2021

NEW POTENTIAL PHARMACEUTICAL DRUG LEADS BY HBC

05.11.2021

European webshops

UK Webshop

Shipping products inside the UK

German and Swiss webshop

Shipping products inside Germany and Switzerland

Norwegian webshop

Shipping products inside Norway